Title 35 Public Health and Safety

35-4-902. Definitions.

(a) As used in this article: (i) "Opiate antagonist" means any device or medication approved by the United States food and drug administration for the treatment of an opiate related drug overdose; (ii) "Opiate related drug overdose" means a condition, including extreme physical illness, a decreased level of consciousness or respiratory depression resulting from the consumption or use of an opioid, or another substance with which an opioid was combined, that a reasonable person would believe to require medical assistance; (iii) "Pharmacist" means any person licensed under Wyoming statutes as a pharmacist and who is practicing within the scope of their license; (iv) "Practitioner" means any person licensed under Wyoming statutes as a physician, physician assistant or advanced practice registered nurse and who is practicing within the scope of their license; (v) "Standing order" means an order transmitted electronically or in writing by a practitioner for a drug or device for a patient or multiple patients with whom no prescriber-patient relationship exists; (vi) "Entity" means any person as defined in W.S. 8-1-102(a)(vi), and includes the University of Wyoming and Wyoming community colleges, who employs persons who, in the course of their official duties or business, may encounter a person experiencing anaphylaxis or an opioid related drug overdose; (vii) "Opioid" or "opiate" means an opiumlike compound that binds to one (1) or more of the major opioid receptors in the body; (viii) "Epinephrine" means a device or method that administers the drug epinephrine to a person experiencing anaphylaxis and includes epipens, nasal sprays or any other device or method under a different name used for emergency epinephrine delivery for the treatment of anaphylaxis and which device or method is approved by the United States food and drug administration.